Burooj Al-Saeeda for Import is a strategic branch of Al-Gaish Pharmaceutical & Trading Group, established to strengthen our import operations and expand our pharmaceutical portfolio in the Yemeni market.
As part of the Al-Gaish Group, Burooj Al-Saeeda focuses on sourcing and importing high-quality pharmaceutical products, medical supplies, and healthcare solutions from globally certified manufacturers. The branch operates under strict compliance with international regulatory standards to ensure safety, efficacy, and reliability.
Through this expansion, we aim to introduce new international agencies and partnerships, enhance supply chain efficiency, and support the growing healthcare needs of the region.
Burooj Al-Saeeda represents our commitment to sustainable growth, trusted partnerships, and delivering affordable, high-quality healthcare solutions across Yemen.
This branch was established and founded as a result of the strong determination and ambitious vision of the Algaish Group’s management, represented by the Chairman of the Board, Mr. Gaish MUhsen Hadi Al-Gaish, who leads a strategic outlook focused on sustainable expansion and strengthening the group’s position in the pharmaceutical and trading sectors at both regional and global levels.
This establishment is an extension of a long-standing journey of success built on deep expertise, structured corporate management, and the development of reliable international partnerships with leading global pharmaceutical and medical supply companies. It also reflects the management’s commitment to continuous improvement, enhancing supply chain efficiency, and ensuring the provision of high-quality products that meet the needs of the Yemeni market in line with international standards.
Under the leadership of the Chairman, the management continues to work with innovation and ambition to expand the group’s operations, launch new agencies, and build a strong and influential presence in global pharmaceutical markets, further strengthening the company’s position as a trusted partner in the healthcare sector.

